R.PR
REGISTERED-PRINCIPAL REGISTER
01/18/2022
Back to search
Official data from USPTO
ONGENTYS (OPICAPONE) CAPSULES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
01/18/2022
Trademark type
Combined
Nice classes
5
Filing date
09/17/2020
Registration date
01/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/18/2022
Last transaction
01/18/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-04-00
First use in commerce
2020-04-00
Drawing code
3
Owner type
99
Owner location
Coronado, PT
Examiner
MONINGHOFF, KIM TERESA
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized blue wording "ONGENTYS" and the stylized light blue wording "(OPICAPONE) CAPSULES" combined with a design of two curved lines in shades of light blue.
Holders and representatives
Holders
BIAL - Portela & Cª., S.A.
Representatives
Ryan A. McGonigle HODGSON RUSS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMMOVEMENT DISORDERSPARKINSON'S DISEASE AND PARKINSONIAN DISORDERSRESTLESS LEGS SYNDROME
Publications
History of USPTO decisions and trademark events.
20 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/17/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/16/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/16/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/13/2021
IUAF
USE AMENDMENT FILED
11/12/2021
EISU
TEAS STATEMENT OF USE RECEIVED
11/12/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/16/2021
PUBO
PUBLISHED FOR OPPOSITION
03/16/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/24/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/05/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/05/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/05/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/05/2021
DOCK
ASSIGNED TO EXAMINER
02/01/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/27/2020
NWAP
NEW APPLICATION ENTERED
09/21/2020
Continuous trademark protection
Get notified about every new filing that threatens ONGENTYS (OPICAPONE) CAPSULES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.